Renee Wagner

669 total citations
5 papers, 247 citations indexed

About

Renee Wagner is a scholar working on Cellular and Molecular Neuroscience, Neurology and Infectious Diseases. According to data from OpenAlex, Renee Wagner has authored 5 papers receiving a total of 247 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Cellular and Molecular Neuroscience, 5 papers in Neurology and 0 papers in Infectious Diseases. Recurrent topics in Renee Wagner's work include Neurological disorders and treatments (5 papers), Nerve injury and regeneration (5 papers) and Parkinson's Disease Mechanisms and Treatments (3 papers). Renee Wagner is often cited by papers focused on Neurological disorders and treatments (5 papers), Nerve injury and regeneration (5 papers) and Parkinson's Disease Mechanisms and Treatments (3 papers). Renee Wagner collaborates with scholars based in United States, Cyprus and Bulgaria. Renee Wagner's co-authors include Greg A. Gerhardt, John T. Slevin, Don M. Gash, Ashley Walton, A. Byron Young, Richard J. Kryscio, Charles D. Smith, Charles D. Smith, Craig G. van Horne and Jorge E. Quintero and has published in prestigious journals such as Journal of neurosurgery, Cell and Tissue Research and Neurosurgical FOCUS.

In The Last Decade

Renee Wagner

5 papers receiving 240 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Renee Wagner United States	5	193	99	80	55	36	5	247
Ingrid Str�mberg Sweden	7	288 1.5×	111 1.1×	96 1.2×	102 1.9×	26 0.7×	8	350
Mark J. Nolt United States	7	313 1.6×	96 1.0×	85 1.1×	53 1.0×	73 2.0×	11	420
Simona Gribaudo France	9	121 0.6×	74 0.7×	152 1.9×	91 1.7×	18 0.5×	14	314
Sébastien Brot France	10	134 0.7×	81 0.8×	92 1.1×	55 1.0×	10 0.3×	14	268
Durga Praveen Meka Germany	10	171 0.9×	109 1.1×	178 2.2×	59 1.1×	26 0.7×	13	374
Luca Bartesaghi Switzerland	8	162 0.8×	30 0.3×	146 1.8×	43 0.8×	33 0.9×	11	308
Karsten Tillack Germany	4	132 0.7×	69 0.7×	122 1.5×	44 0.8×	21 0.6×	4	222
William Rodemer United States	11	184 1.0×	24 0.2×	65 0.8×	59 1.1×	18 0.5×	16	321
Charlotte M. Ermine Australia	9	129 0.7×	60 0.6×	149 1.9×	59 1.1×	16 0.4×	20	336
Frank S. Adams United States	9	281 1.5×	74 0.7×	178 2.2×	121 2.2×	46 1.3×	9	407

Countries citing papers authored by Renee Wagner

Since Specialization

Citations

This map shows the geographic impact of Renee Wagner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Renee Wagner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Renee Wagner more than expected).

Fields of papers citing papers by Renee Wagner

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Renee Wagner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Renee Wagner. The network helps show where Renee Wagner may publish in the future.

Co-authorship network of co-authors of Renee Wagner

This figure shows the co-authorship network connecting the top 25 collaborators of Renee Wagner. A scholar is included among the top collaborators of Renee Wagner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Renee Wagner. Renee Wagner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

5 of 5 papers shown

1.

Gash, Don M., Greg A. Gerhardt, Luke H. Bradley, Renee Wagner, & John T. Slevin. (2020). GDNF clinical trials for Parkinson’s disease: a critical human dimension. Cell and Tissue Research. 382(1). 65–70. 17 indexed citations

2.

Horne, Craig G. van, Jorge E. Quintero, John T. Slevin, et al.. (2018). Peripheral nerve grafts implanted into the substantia nigra in patients with Parkinson’s disease during deep brain stimulation surgery: 1-year follow-up study of safety, feasibility, and clinical outcome. Journal of neurosurgery. 129(6). 1550–1561. 24 indexed citations

3.

Horne, Craig G. van, Jorge E. Quintero, Julie A. Gurwell, et al.. (2016). Implantation of autologous peripheral nerve grafts into the substantia nigra of subjects with idiopathic Parkinson's disease treated with bilateral STN DBS: a report of safety and feasibility. Journal of neurosurgery. 126(4). 1140–1147. 16 indexed citations

4.

Slevin, John T., Don M. Gash, Charles D. Smith, et al.. (2007). Unilateral intraputamenal glial cell line–derived neurotrophic factor in patients with Parkinson disease: response to 1 year of treatment and 1 year of withdrawal. Journal of neurosurgery. 106(4). 614–620. 144 indexed citations

5.

Slevin, John T., Don M. Gash, Charles D. Smith, et al.. (2006). Unilateral intraputaminal glial cell line–derived neurotrophic factor in patients with Parkinson disease: response to 1 year each of treatment and withdrawal. Neurosurgical FOCUS. 20(5). 1–7. 46 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact